In the case of tamoxifen, for example, a breast cancer drug previously only used for treatment, but later shown to have preventative benefits as well, no increase in prescribing was seen between the drug being recommended for the new use in summer 2013, and a review of National Prescription Records a year later.
Figure 1 shows a representative example of a set of breast images used in the analysis.
This family is a good example of a typical Hereditary Breast and Ovarian Cancer (HBOC) family.
MDA-MB-231 are also an example of a triple-negative breast cancer cells, which express neither hormone receptors nor HER2 and are therefore difficult to target with current chemotherapeutic strategies.
Consider an example of a patient with a breast lump approaching an oncologist for treatment at a tertiary care facility.
The main focus of the paper is that the MAST (microtubule-associated serine threonine) kinase and Notch gene families are repeatedly fused - in around 4% and 6% of cases, respectively - and one fusion was present in two cases, qualifying as the first example of a recurrent fusion in breast cancer.
So, Sauter' study [ 65] is a promising example of how breast microenvironment biomarkers (that alone did not reach the excellence of the clinical/diagnostic/prognostic significance in pre and post-menopause, in pre-cancerous and cancer conditions) may be really useful only through a combination, providing predictive ability near to 1.0.
Our investigations are the first to show that PEA3 is a transcriptional activator of Notch-1 and Notch-4 in MDA-MB-231 breast cancer cells, an example of triple-negative breast cancer.
One exciting example of a rational, targeted approach to breast cancer treatment is HerceptinTM (Genentech, San Francisco, California, USA), a recombinant humanized antibody targeted to ErbB2.
